A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S ...

In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...

The following is a summary of “Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of ...

Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...

18 The time relations between the onset of myocardial infarction and death have not been adequately studied. Most reviews concerning the immediate prognosis of myocardial infarction lump all ...

Although the quantitative and serial changes in blood enzymes observed in myocardial infarction are characteristic, they are not specific in that other states such as those of liver, biliary and ...

The following is a summary of “Bleeding complications, coagulation disorders, and their management in acute myocardial ...

The FDA has approved Flyrcado™ for positron emission tomography myocardial perfusion imaging under rest or stress in adult patients.

Higher frequency and severity of acute exacerbations of COPD increases the risk for myocardial infarction and pulmonary embolism.

Asamedic and Bormioli Pharma join forces to commercialize Coxor™, a liquid-form heart attack medication, utilizing Bormioli ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...